Johnson & Johnson wins California lawsuit claiming asbestos in talc caused cancer

A California jury on Thursday ruled in favor of Johnson & Johnson in a lawsuit by a woman who said she developed the cancer mesothelioma after being exposed to asbestos in the company's talc-based products including J&J's Baby Powder.

The Los Angeles Superior Court jury's verdict came in the first trial centering on claims that J&J's talc products contained asbestos. J&J is separately battling thousands of cases claiming those products can cause ovarian cancer.

RELATED: Here's a look at some of the most popular Johnson & Johnson products:

15 PHOTOS
Johnson & Johnson brand products
See Gallery
Johnson & Johnson brand products

Johnson's baby wash is arranged for a photograph in Tiskilwa, Illinois, U.S., on Thursday, July 2, 2015. Johnson & Johnson is expected to report quarterly earnings on July 14, 2015.

Photographer: Daniel Acker/Bloomberg via Getty Images

Johnson & Johnson Band-Aid brand bandages sit on display in a supermarket in Princeton, Illinois, U.S., on Friday, Oct. 12, 2012. Johnson & Johnson is scheduled to release earnings data on Oct. 16.

Photographer: Daniel Acker/Bloomberg via Getty Images

Johnson & Johnson (J&J) Listerine brand freshburst mouthwash bottles move through the production line on a conveyor at the J&J consumer healthcare products plant in Lititz, Pennsylvania, U.S., on Wednesday, June 18, 2014. Johnson & Johnson, the world's biggest health-care products company, beat expectations in its first-quarter earnings release in April and raised its 2014 forecast by focusing on new drugs and reducing its reliance on medical devices. J&J is expected to release second-quarter earnings figures on July 15.

Photographer: Andrew Harrer/Bloomberg via Getty Images

Johnson's baby shampoo is arranged for a photograph in Tiskilwa, Illinois, U.S., on Thursday, July 2, 2015. Johnson & Johnson is expected to report quarterly earnings on July 14, 2015.

Photographer: Daniel Acker/Bloomberg via Getty Images

Bottles of Johnson's baby powder, produced by Johnson & Johnson, sit on display at a Tesco supermarket in London, U.K., on Tuesday, April 19, 2011. Johnson & Johnson, reeling from more than 50 drug and device recalls since the start of 2010, is trying to recapture its younger self by digesting Synthes Inc.

Photographer: Simon Dawson/Bloomberg via Getty Images

Johnson & Johnson Neosporin brand ointment sits on display in a supermarket in Princeton, Illinois, U.S., on Friday, Oct. 12, 2012. Johnson & Johnson is scheduled to release earnings data on Oct. 16.

Photographer: Daniel Acker/Bloomberg via Getty Images

Bottles of Johnson's baby conditioner, produced by Johnson & Johnson, sit on display at a Tesco supermarket in London, U.K., on Tuesday, April 19, 2011. Johnson & Johnson, reeling from more than 50 drug and device recalls since the start of 2010, is trying to recapture its younger self by digesting Synthes Inc.

Photographer: Simon Dawson/Bloomberg via Getty Images

Johnson & Johnson (J&J) Johnson's brand baby oil bottles move through the production line at the J&J consumer healthcare products plant in Lititz, Pennsylvania, U.S., on Wednesday, June 18, 2014. Johnson & Johnson, the world's biggest health-care products company, beat expectations in its first-quarter earnings release in April and raised its 2014 forecast by focusing on new drugs and reducing its reliance on medical devices. J&J is expected to release second-quarter earnings figures on July 15.

Photographer: Andrew Harrer/Bloomberg via Getty Images

Johnson & Johnson Band-Aid brand bandages sit on display in a supermarket in Princeton, Illinois, U.S., on Friday, Oct. 12, 2012. Johnson & Johnson is scheduled to release earnings data on Oct. 16.

Photographer: Daniel Acker/Bloomberg via Getty Images

NEW YORK - OCTOBER 11: Johnson & Johnson, infants? nonprescription cough and cold products are displayed on a shelf at a pharmacy October 11, 2007 in the Brooklyn borough, of New York City. The Consumer Healthcare Products Association announced Thursday that Johnson & Johnson, Wyeth and other manufactures of infants? nonprescription cough and cold products are recalling some medicines in the United States because of the potential danger of overdose.

(Photo by Spencer Platt/Getty Images)

Johnson & Johnson Neutrogena brand facial soap is arranged for a photograph in Tiskilwa, Illinois, U.S., on Thursday, July 2, 2015. Johnson & Johnson is expected to report quarterly earnings on July 14, 2015.

Photographer: Daniel Acker/Bloomberg via Getty Images

Johnson & Johnson (J&J) Listerine brand freshburst mouthwash bottles move through the production line on a conveyor at the J&J consumer healthcare products plant in Lititz, Pennsylvania, U.S., on Wednesday, June 18, 2014. Johnson & Johnson, the world's biggest health-care products company, beat expectations in its first-quarter earnings release in April and raised its 2014 forecast by focusing on new drugs and reducing its reliance on medical devices. J&J is expected to release second-quarter earnings figures on July 15.

Photographer: Andrew Harrer/Bloomberg via Getty Images

Johnson & Johnson Band-Aid brand bandages sit on display in a supermarket in Princeton, Illinois, U.S., on Friday, Oct. 12, 2012. Johnson & Johnson is scheduled to release earnings data on Oct. 16.

Photographer: Daniel Acker/Bloomberg via Getty Images

UNITED STATES - JANUARY 23: Johnson & Johnson baby oil is arranged on the shelf for an illustration at Skenderian Apothecary in Cambridge, Massachusetts on Tuesday, Jan. 23, 2007. Johnson & Johnson, the world's biggest health-care products company, said profit rose 3.5 percent, led by sales of the Risperdal schizophrenia drug. The shares fell as revenue overall missed analyst expectations.

(Photo by Jb Reed/Bloomberg via Getty Images)

HIDE CAPTION
SHOW CAPTION
of
SEE ALL
BACK TO SLIDE

Reuters watched the verdict through Courtroom View Network, which broadcast it online.

(Reporting by Nate Raymond in Boston; Editing by Jeffrey Benkoe)

Read Full Story

Markets

NASDAQ 6,936.58 80.06 1.17%
S&P 500 2,675.81 23.80 0.90%
DJIA 24,651.74 143.08 0.58%
NIKKEI 225 22,553.22 -141.23 -0.62%
HANG SENG 28,848.11 -318.27 -1.09%
DAX 13,103.56 35.48 0.27%
USD (per EUR) 1.17 0.00 -0.21%
USD (per CHF) 0.99 0.00 0.20%
JPY (per USD) 112.57 0.19 0.17%
GBP (per USD) 1.33 -0.01 -0.82%

Can't get enough business news?

Sign up for Finance Report by AOL and get everything from retailer news to the latest IPOs delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.